バイオシミラーモノクローナル抗体のグローバル市場2021

• 英文タイトル：Global Biosimilar Monoclonal Antibodies Sales Market Report 2021

• レポートコード：QAF27592
• 出版社/出版日：QYResearch / 2021年4月21日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、138ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界のバイオシミラーモノクローナル抗体市場について種類別（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他）、用途別（腫瘍、自己免疫疾患、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・バイオシミラーモノクローナル抗体市場の概要
・世界の主要地域別バイオシミラーモノクローナル抗体市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のバイオシミラーモノクローナル抗体市場規模2016-2021：種類別（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他）
・世界のバイオシミラーモノクローナル抗体市場予測2012-2027：種類別（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他）
・世界のバイオシミラーモノクローナル抗体市場規模2016-2021：用途別（腫瘍、自己免疫疾患、その他）
・世界のバイオシミラーモノクローナル抗体市場予測2012-2027：用途別（腫瘍、自己免疫疾患、その他）
・バイオシミラーモノクローナル抗体のアメリカ市場規模と予測2016-2021
・バイオシミラーモノクローナル抗体のヨーロッパ市場規模と予測2016-2021
・バイオシミラーモノクローナル抗体の中国市場規模と予測2016-2021
・バイオシミラーモノクローナル抗体の日本市場規模と予測2016-2021
・バイオシミラーモノクローナル抗体の東南アジア市場規模と予測2016-2021
・バイオシミラーモノクローナル抗体のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Celltrion、Pfizer (Hospira)、3SBIO、Novartis (Sandoz)、Dr Reddy’s、Celgen Biopharma、Cadila Healthcare、Hisun Pharma、Torrent Pharmaceuticals）
・バイオシミラーモノクローナル抗体の製造コスト分析
・販売チャネル、流通業者、顧客
・バイオシミラーモノクローナル抗体の市場動向・機会・課題
・調査の結論

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.

Market Analysis and Insights: Global Biosimilar Monoclonal Antibodies Market
The global Biosimilar Monoclonal Antibodies market was valued at US$ 7588.6 in 2020 and will reach US$ 32910 million by the end of 2027, growing at a CAGR of 27.7% during 2022-2027.

Global Biosimilar Monoclonal Antibodies Scope and Market Size
The global Biosimilar Monoclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Segment by Application
Oncology
Autoimmune Disease
Other

The Biosimilar Monoclonal Antibodies market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilar Monoclonal Antibodies market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals

レポート目次

1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Biosimilar Monoclonal Antibodies Product Scope
1.2 Biosimilar Monoclonal Antibodies Segment by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Sales by Type (2016 & 2021 & 2027)
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Biosimilar Monoclonal Antibodies Segment by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Biosimilar Monoclonal Antibodies Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilar Monoclonal Antibodies Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilar Monoclonal Antibodies Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilar Monoclonal Antibodies Price Trends (2016-2027)

2 Biosimilar Monoclonal Antibodies Estimates and Forecasts by Region
2.1 Global Biosimilar Monoclonal Antibodies Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
2.4.3 China Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
2.4.6 India Biosimilar Monoclonal Antibodies Estimates and Projections (2016-2027)
3 Global Biosimilar Monoclonal Antibodies Competition Landscape by Players
3.1 Global Top Biosimilar Monoclonal Antibodies Players by Sales (2016-2021)
3.2 Global Top Biosimilar Monoclonal Antibodies Players by Revenue (2016-2021)
3.3 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2020)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biosimilar Monoclonal Antibodies Market Size by Type
4.1 Global Biosimilar Monoclonal Antibodies Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilar Monoclonal Antibodies Price by Type (2016-2021)
4.2 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2022-2027)
5 Global Biosimilar Monoclonal Antibodies Market Size by Application
5.1 Global Biosimilar Monoclonal Antibodies Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilar Monoclonal Antibodies Price by Application (2016-2021)
5.2 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2022-2027)

6 North America Biosimilar Monoclonal Antibodies Market Facts & Figures
6.1 North America Biosimilar Monoclonal Antibodies Sales by Company
6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
6.2 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Type
6.2.1 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Application
6.3.1 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilar Monoclonal Antibodies Sales Breakdown by Application (2022-2027)

7 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures
7.1 Europe Biosimilar Monoclonal Antibodies Sales by Company
7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
7.2 Europe Biosimilar Monoclonal Antibodies Sales Breakdown by Type
7.2.1 Europe Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilar Monoclonal Antibodies Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Biosimilar Monoclonal Antibodies Market Facts & Figures
8.1 China Biosimilar Monoclonal Antibodies Sales by Company
8.1.1 China Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
8.1.2 China Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
8.2 China Biosimilar Monoclonal Antibodies Sales Breakdown by Type
8.2.1 China Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
8.3 China Biosimilar Monoclonal Antibodies Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)

9 Japan Biosimilar Monoclonal Antibodies Market Facts & Figures
9.1 Japan Biosimilar Monoclonal Antibodies Sales by Company
9.1.1 Japan Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
9.1.2 Japan Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
9.2 Japan Biosimilar Monoclonal Antibodies Sales Breakdown by Type
9.2.1 Japan Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilar Monoclonal Antibodies Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Biosimilar Monoclonal Antibodies Market Facts & Figures
10.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales by Company
10.1.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Biosimilar Monoclonal Antibodies Market Facts & Figures
11.1 India Biosimilar Monoclonal Antibodies Sales by Company
11.1.1 India Biosimilar Monoclonal Antibodies Sales by Company (2016-2021)
11.1.2 India Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021)
11.2 India Biosimilar Monoclonal Antibodies Sales Breakdown by Type
11.2.1 India Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilar Monoclonal Antibodies Sales Breakdown by Type (2022-2027)
11.3 India Biosimilar Monoclonal Antibodies Sales Breakdown by Application
11.3.1 India Biosimilar Monoclonal Antibodies Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilar Monoclonal Antibodies Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business
12.1 Celltrion
12.1.1 Celltrion Corporation Information
12.1.2 Celltrion Business Overview
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
12.1.5 Celltrion Recent Development
12.2 Pfizer (Hospira)
12.2.1 Pfizer (Hospira) Corporation Information
12.2.2 Pfizer (Hospira) Business Overview
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
12.2.5 Pfizer (Hospira) Recent Development
12.3 3SBIO
12.3.1 3SBIO Corporation Information
12.3.2 3SBIO Business Overview
12.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered
12.3.5 3SBIO Recent Development
12.4 Novartis (Sandoz)
12.4.1 Novartis (Sandoz) Corporation Information
12.4.2 Novartis (Sandoz) Business Overview
12.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
12.4.5 Novartis (Sandoz) Recent Development
12.5 Dr Reddy’s
12.5.1 Dr Reddy’s Corporation Information
12.5.2 Dr Reddy’s Business Overview
12.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered
12.5.5 Dr Reddy’s Recent Development
12.6 Celgen Biopharma
12.6.1 Celgen Biopharma Corporation Information
12.6.2 Celgen Biopharma Business Overview
12.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
12.6.5 Celgen Biopharma Recent Development
12.7 Cadila Healthcare
12.7.1 Cadila Healthcare Corporation Information
12.7.2 Cadila Healthcare Business Overview
12.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
12.7.5 Cadila Healthcare Recent Development
12.8 Hisun Pharma
12.8.1 Hisun Pharma Corporation Information
12.8.2 Hisun Pharma Business Overview
12.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
12.8.5 Hisun Pharma Recent Development
12.9 Torrent Pharmaceuticals
12.9.1 Torrent Pharmaceuticals Corporation Information
12.9.2 Torrent Pharmaceuticals Business Overview
12.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
12.9.5 Torrent Pharmaceuticals Recent Development

13 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
13.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
13.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilar Monoclonal Antibodies Distributors List
14.3 Biosimilar Monoclonal Antibodies Customers

15 Market Dynamics
15.1 Biosimilar Monoclonal Antibodies Market Trends
15.2 Biosimilar Monoclonal Antibodies Drivers
15.3 Biosimilar Monoclonal Antibodies Market Challenges
15.4 Biosimilar Monoclonal Antibodies Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Biosimilar Monoclonal Antibodies Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Biosimilar Monoclonal Antibodies Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Region (2016-2021)
Table 5. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 6. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Biosimilar Monoclonal Antibodies Revenue Share by Region (2016-2021)
Table 8. Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Biosimilar Monoclonal Antibodies Revenue Share Forecast by Region (2022-2027)
Table 12. Global Biosimilar Monoclonal Antibodies Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Biosimilar Monoclonal Antibodies Sales Share by Company (2016-2021)
Table 14. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Biosimilar Monoclonal Antibodies Revenue Share by Company (2016-2021)
Table 16. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2020)
Table 17. Global Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites and Area Served
Table 19. Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2016-2021)
Table 22. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2016-2021)
Table 23. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2016-2021)
Table 25. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2022-2027)
Table 26. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2022-2027)
Table 28. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2022-2027)
Table 29. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2016-2021)
Table 30. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2016-2021)
Table 31. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Application (2016-2021)
Table 33. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2022-2027)
Table 34. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2022-2027)
Table 35. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2022-2027)
Table 37. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Application (2022-2027)
Table 38. North America Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 39. North America Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 40. North America Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 42. North America Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 43. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 44. North America Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 45. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 46. North America Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 47. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 48. North America Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 49. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 50. Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 51. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 52. Europe Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 54. Europe Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 55. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 56. Europe Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 57. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 58. Europe Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 59. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 60. Europe Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 61. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 62. China Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 63. China Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 64. China Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 66. China Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 67. China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 68. China Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 69. China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 70. China Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 71. China Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 72. China Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 73. China Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 74. Japan Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 75. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 76. Japan Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 78. Japan Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 79. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 80. Japan Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 81. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 82. Japan Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 83. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 84. Japan Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 85. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 98. India Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2016-2021)
Table 99. India Biosimilar Monoclonal Antibodies Sales Market Share by Company (2016-2021)
Table 100. India Biosimilar Monoclonal Antibodies Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2016-2021)
Table 102. India Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
Table 103. India Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 104. India Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
Table 105. India Biosimilar Monoclonal Antibodies Sales Market Share by Type (2022-2027)
Table 106. India Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
Table 107. India Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 108. India Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
Table 109. India Biosimilar Monoclonal Antibodies Sales Market Share by Application (2022-2027)
Table 110. Celltrion Corporation Information
Table 111. Celltrion Description and Business Overview
Table 112. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Celltrion Biosimilar Monoclonal Antibodies Product
Table 114. Celltrion Recent Development
Table 115. Pfizer (Hospira) Corporation Information
Table 116. Pfizer (Hospira) Description and Business Overview
Table 117. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product
Table 119. Pfizer (Hospira) Recent Development
Table 120. 3SBIO Corporation Information
Table 121. 3SBIO Description and Business Overview
Table 122. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. 3SBIO Biosimilar Monoclonal Antibodies Product
Table 124. 3SBIO Recent Development
Table 125. Novartis (Sandoz) Corporation Information
Table 126. Novartis (Sandoz) Description and Business Overview
Table 127. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product
Table 129. Novartis (Sandoz) Recent Development
Table 130. Dr Reddy’s Corporation Information
Table 131. Dr Reddy’s Description and Business Overview
Table 132. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Dr Reddy’s Biosimilar Monoclonal Antibodies Product
Table 134. Dr Reddy’s Recent Development
Table 135. Celgen Biopharma Corporation Information
Table 136. Celgen Biopharma Description and Business Overview
Table 137. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Celgen Biopharma Biosimilar Monoclonal Antibodies Product
Table 139. Celgen Biopharma Recent Development
Table 140. Cadila Healthcare Corporation Information
Table 141. Cadila Healthcare Description and Business Overview
Table 142. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Cadila Healthcare Biosimilar Monoclonal Antibodies Product
Table 144. Cadila Healthcare Recent Development
Table 145. Hisun Pharma Corporation Information
Table 146. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Hisun Pharma Description and Business Overview
Table 148. Hisun Pharma Biosimilar Monoclonal Antibodies Product
Table 149. Hisun Pharma Recent Development
Table 150. Torrent Pharmaceuticals Corporation Information
Table 151. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Torrent Pharmaceuticals Description and Business Overview
Table 153. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product
Table 154. Torrent Pharmaceuticals Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Biosimilar Monoclonal Antibodies Distributors List
Table 158. Biosimilar Monoclonal Antibodies Customers List
Table 159. Biosimilar Monoclonal Antibodies Market Trends
Table 160. Biosimilar Monoclonal Antibodies Market Drivers
Table 161. Biosimilar Monoclonal Antibodies Market Challenges
Table 162. Biosimilar Monoclonal Antibodies Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Product Picture
Figure 2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Other Examples
Figure 9. Global Biosimilar Monoclonal Antibodies Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Biosimilar Monoclonal Antibodies Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Biosimilar Monoclonal Antibodies Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Biosimilar Monoclonal Antibodies Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Biosimilar Monoclonal Antibodies Players Market Share by Revenue in Biosimilar Monoclonal Antibodies: 2016 & 2020
Figure 28. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2016-2021)
Figure 30. Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2016-2021)
Figure 32. Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 34. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 35. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 36. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 37. China Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 38. China Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 39. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 40. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 41. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 42. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 43. India Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 44. India Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure 47. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure 48. Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Global Bispecific Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5624 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、二重特異性モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、ア...

世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-3853 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、関節炎モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レミケード、ヒュミラ、エンブレル、リツキサン、オレンシア、アクテムラ、シンポニ、シムジア）、用途別市場規模（関節リウマチ、変形性...

バイオシミラー薬のグローバル市場2021

Global Biosimilar Drug Sales Market Report 2021
QAF27591 2021年4月14日 133Pages
本市場調査資料では、世界のバイオシミラー薬市場について種類別（注射、錠剤、その他）、用途別（強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格...

インターフェロンα-2aバイオシミラーのグローバル市場2021

Global Interferon Alpha-2a Biosimilar Sales Market Report 2021
QAF27744 2021年4月8日 138Pages
本市場調査資料では、世界のインターフェロンα-2aバイオシミラー市場について種類別（長持ちタイプ、一般タイプ）、用途別（C型肝炎、B型肝炎、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、...

モノクローナル抗体診断試薬のグローバル市場2021

Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2021
QAF27793 2021年4月13日 138Pages
本市場調査資料では、世界のモノクローナル抗体診断試薬市場について種類別（酵素免疫測定法、ドット免疫金濾過アッセイ、二重抗原サンドイッチ化学発光法、組換え免疫ブロットアッセイ）、用途別（腫瘍モニタリング、ウイルス性肝炎診断、性感染症診断、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、...

世界の二重特異性抗体市場規模・現状・予測（2021年-2027年）

Global Bi-Specific Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5623 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、二重特異性抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フラグメントベース抗体、IgGベース抗体）、用途別市場規模（がん、血友病、その他非がん性疾患）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のモノクローナル抗体滅菌注射薬産業調査2019-2025

Global Monoclonal Antibodies Sterile Injectable Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9NV16518 2019年11月18日 115Pages
※本調査レポートでは、世界のモノクローナル抗体滅菌注射薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。モノクローナル抗体滅菌注射薬の種類別には、In Vivo生産薬、In Vitro生産薬に、用途別には、病院薬...

世界のモノクローナル抗体滅菌注射薬産業調査2019-2025

世界のナノ抗体市場規模・現状・予測（2021年-2027年）

Global Nano Antibodies Market Size, Status and Forecast 2021-2027
QFJ1-5874 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ナノ抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一価ナノボディ、多価・多重特異性ナノボディ、融合ナノボディ）、用途別市場規模（in vitro疾患検出、in vivo非侵襲的診断、腫瘍標的療法...

世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年）

Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2021-2027
QFJ1-4941 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、タンパク質＆抗体＆核酸デリバリー技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、...

世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年） A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antig…
世界の関節炎モノクローナル抗体市場規模・現状・予測（2021年-2027年） Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases Market Analysis and Insights: Global Arthritis Monoclonal Antibodies Market The global Arthritis Monoclonal Antibodies market size is project…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
バイオシミラー薬のグローバル市場2021 Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or a…